Application Nr Approved Date Route Status External Links
BLA761025 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Praxbind Is Indicated In Patients Treated With Pradaxa When Reversal Of The Anticoagulant Effects Of Dabigatran Is Needed: For Emergency Surgery/urgent Procedures In Life-Threatening Or Uncontrolled Bleeding Praxbind Is A Humanized Monoclonal Antibody Fragment (Fab) Indicated In Patients Treated With Pradaxa ® When Reversal Of The Anticoagulant Effects Of Dabigatran Is Needed: For Emergency Surgery/urgent Procedures In Life-Threatening Or Uncontrolled Bleeding ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Idarucizumab

Comments